|
|
||||||||
J Thorac Cardiovasc Surg 2002;123:225-231
© 2002 The American Association for Thoracic Surgery
Cardiopulmonary Support and Physiology (CSP) |
From the Department of Cardiology and Cardiac Surgery, University "G. D'Annunzio," Chieti, Italy.
Received for publication May 15, 2001. Revisions requested July 11, 2001; revisions received Aug 2, 2001. Accepted for publication Aug 3, 2001. Address for reprints: Antonio Maria Calafiore, MD, "G. D'Annunzio" University, Division of Cardiac Surgery, c/o S. Camillo de' Lellis Hospital, via C. Forlanini, 50 66100 Chieti Italy (E-mail: calafiore@ unich.it).
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
The increasing use of the right internal thoracic artery (RITA) was due to recent reports that focused on the improved quality of the late results when both thoracic arteries are used.
7,8 Even if some of these statements need to be confirmed by further studies, it seems reasonable that grafting the left coronary system with both thoracic arteries can provide better long-term results.
We reviewed our experience to evaluate the long-term results of the use of the RA or RITA in the lateral wall.
| Materials and methods |
|---|
|
|
|---|
|
|
The RA was used in the presence of a stenosis of 70% or greater, with expected high runoff (no previous myocardial infarction and target coronary vessel of reasonable size). The RITA was used in younger patients when there was no indication for the RA or according to the surgeon's preference.
Surgical technique
The RA was evaluated in all cases with the Allen test, and results were considered negative when hand vascularization became normal in less than 6 seconds. The graft was harvested only from the nondominant forearm. The RA was dissected through a skin incision starting 3 cm proximal to the wrist and ending 3 cm distal to the elbow. All the side branches were occluded with Hemoclip devices (Weck Closure Systems, Research Triangle Park, NC) or ligated. The RITA was harvested as a pedicle in 26 patients and skeletonized in 123 patients. Surgical technique has already been reported.
9
In group A the RA was proximally anastomosed to the LITA in 120 patients and to the ascending aorta in 19 patients. When the aorta was the RA blood source, the proximal anastomosis was performed during crossclamping. When possible, a papaverine solution (1 mg/1 mL) was injected inside the RA graft, which was then distally clipped to allow pharmacologic dilation.
The LITA was used in all cases as an in situ graft. The RITA was used in situ in 91 patients and as a free graft in the remaining 58 patients (ie, as a Y graft from the LITA in 53 patients and directly from the aorta in 5 patients). The surgical technique of Y grafting has already been described.
10,11 When in situ, all the RITAs reached the lateral wall by passing over the aorta.
All the patients were operated on with cardiopulmonary bypass and intermittent antegrade warm blood cardioplegia.
12
Postoperative course
From the operating room, patients were admitted to the intensive care unit and from there to the regular ward. They were followed up in our outpatient clinic 3, 6, and 12 months after their operations and each year thereafter. The more recent information was obtained by calling the patients or the referring cardiologist. If patients agreed, a coronary angiogram was performed during a brief hospitalization. The quality of the anastomoses was graded according to the method of FitzGibbon and colleagues.
13 Follow-up was 100% complete.
Statistical analysis
Results are expressed as mean values ± SD unless otherwise indicated. Statistical analysis comparing 2 groups was performed with unpaired 2-tailed t testing for means or with the
2 test for categorical variables. Survival and event-free survival curves were obtained with the Kaplan-Meier method (SPSS software; SPSS, Inc, Chicago, Ill). The statistical significance was calculated with the log rank test.
| Results |
|---|
|
|
|---|
|
Follow-up
Twenty-six (9.2%) patients died after a mean of 27 ± 22 months (minimum-maximum, 2-70 months): 15 in group A and 11 in group B. Causes of deaths(Table 4) were cardiac in 13 patients (6 in group A and 7 in group B, P = .901) and noncardiac in the remaining 13 patients (9 in group A and 4 in group B, P = .200). Nine years after the operation, 8-year survival was 88.1% ± 2.0% (group A: 86.7% ± 2.9% vs group B: 89.6% ± 2.8%, P = .477, Figure 1).
|
|
|
After a mean of 35 ± 28 months (range, 6-95 months), 57 (22.5% of the survivors) patients had a new angiogram. The patency rate (grade A and B) of the LITA-RA anastomoses was 99% (100/101)(Figure 3, A), which is similar to the patency rate of the LITA-RITA anastomoses (100% [33/33], P = .560; Figure 3, B). Grade A anastomoses were 97% for the LITA-RA anastomoses and 100% for the LITA-RITA anastomoses (33/33, P = .740). All the RA-LITA and RITA-LITA intermediate anastomoses were fully patent. Table 5 summarizes the angiographic results. In this cohort of patients, no RAs showed a string sign.
|
|
| Discussion |
|---|
|
|
|---|
When bilateral ITA grafting become more diffuse, the problem of the correct use of the RITA was predominant. The in situ RITA to the right coronary artery system was proved to have the same outcome as the saphenous vein graft.
24 Grafting the in situ RITA to the LAD forces the conduit to cross the midline in a very dangerous manner at the level of the aortic valve and of the pulmonary infundibulum. Bringing the RITA to the lateral wall is less dangerous. The retroaortic route was proposed by Puig and colleagues
25 and was demonstrated to be safe by many authors.
26,27 The overaortic route passes very high at the distal ascending aorta and can be covered by the thymic fat. It seems to be less dangerous in case of a resternotomy.
However, the increased use of the RITA was related to its use as a free graft, not from the aorta (its patency rate is significantly lower than the in situ graft)
28 but connected to the LITA as a T
29 or a Y
10 composite graft.
With the LAD as the target vessel for the LITA, the use of the RITA is directed mainly to the lateral wall. Because this territory is also the main target of RA grafting, we retrospectively analyzed 2 groups of patients, all with a LITA to the LAD and a RITA or an RA in the lateral wall.
Our study showed that, after a mean follow-up of 77 ± 16 months, it was not possible to find any difference between the 2 groups, in terms of both early and late clinical results. Angiographic results were also similar and, after a mean of 35 ± 28 months, comparing LITA-RA and LITA-RITA anastomoses, the patency rate was 99% versus 100%, and the nonrestrictive patency rate was 97% versus 100%. Interestingly, the intermediate anastomoses between the RA or the RITA with the LITA were all patent, demonstrating that the addition of an anastomosis does not impair the possibility of a satisfying late patency rate.
In our experience no RA showed a string sign. It is difficult to understand why. The only possibility is that we tried to follow carefully, since the beginning, strict indications for RA grafting. Royse and colleagues
30 demonstrated that string sign is related to a low-grade coronary stenosis of the target vessel (56% ± 5%). Since the first articles we published on this topic,
2 we believed that the RA had to be used only if a severe stenosis was present, and we carefully followed this policy in all cases. Furthermore, it is possible that patients who refused a new angiogram could have this abnormality. However, it seems that, after the first months after the operation, the RA loses its peculiar characteristics of increased vasomotricity,
3 and this can be at the basis of the reduced incidence of this angiographic aspect of the RA graft.
In conclusion, after a maximum follow-up of 8 years, clinical and angiographic results of RA and RITA grafting in the lateral wall, if the LITA is anastomosed to the LAD, are similar. This fact enhances the possibility of choice of the appropriate graft when coronary revascularization with multiple arterial grafting is scheduled.
| Appendix: Discussion |
|---|
|
|
|---|
I have several questions for Dr Calafiore. What percentage of total patients undergoing coronary bypass grafting by your group does this series of patients represent? Were any of the patients in the early group who had postoperative graft visualization also studied late?
You state that coronary arteries bypassed with RA grafts were carefully selected and had 70% stenosis or greater and were larger and had good runoff. Other than the younger patients mentioned in the manuscript, what were your criteria for choosing the RITA grafts?
What technical and selective features do you think were most beneficial to you in obtaining outstanding patency with these grafts?
Finally, you point out that all of these revascularization procedures were performed with cardiopulmonary bypass, but I am sure many people wonder whether you think you could achieve equally good results using off-pump coronary artery bypass techniques.
Dr Calafiore. Thank you, Dr Tector, for your comments.
The patency rates of the LITA anastomosed to the LAD in this group were very high. There was only one anastomosis that had stenosis in the late angiographic study. Basically, if we compare the LITA to the RA, there is always a trend and a higher patency in the LITA instead of the RA.
In the 4 years of the study, we operated on something like 1200 patients with coronary disease. Therefore, this is not more than 20%, perhaps less, of our global experience.
If I understood correctly, you asked whether I think I can achieve the same results with off-pump operations. This is an interesting question. We did not have such a long-term follow-up, but at least I can tell you that in our experience today, 50% or more of the patients who have a total arterial revascularization have off-pump operations. When we have the time to better understand the midterm or long-term results, I will be able to answer your question, but at this moment, there is no difference between the 2 groups.
You had one other question, Dr Tector.
Dr Tector. The other question was what technical and selective features do you think were most beneficial to you in obtaining outstanding patency with these grafts?
Dr Calafiore. I think that the problem is also selection of the vessel. Basically, I do not believe in extensive revascularization performed with 5 or more grafts. Generally, our policy is to graft the vessels with a good size and a good territory. I think that this is just a key point for having a good patency rate. Of course, there is the technical experience of the surgeon. We must not forget that the surgeon is always a key point for a good operation.
Dr Lawrence Cohn (Brookline, Mass). In the first session of this meeting, we listened to the group in St Louis discuss the RA. What has been your experience with only moderately severe coronary stenosis using those grafts? There is a little concern that the RA for the right coronary, moderate stenosis, or both does not have great long-term patency.
Dr Calafiore. When we started to use the RA, we thought that the problem of the choice of the territory was the key point for the good patency rate of this artery. I think that our good results depend on our strict patient selection. We always preferred to use a good-sized coronary artery with severe stenosis and without myocardial infarction. I think that this is very important.
The reason for the lower patency rate in the right coronary territory is perhaps that the right coronary territory in the great majority of the patients who have operations is the most diseased because the great majority of them had a previous inferior myocardial infarction. The viable territory is not very big, and there are many small vessels. I think that a lot of grafts will fail in the right coronary territory. The circumflex territory is surely the best one, except, of course, the LAD, for an RA graft, but the LAD is the best for the LITA.
Dr Reida M. El Oakley (Singapore). Pharmacologic management of RAs is a highly controversial area. Could you please tell us how you manage the RA from the pharmacologic point of view during and after operation?
Dr Calafiore. In the beginning we were focused on the pharmacologic treatment of the patient with the RA. If you remember, the first attempts with the RA failed because of a lot of technical aspects and because the pathophysiology of the artery was not known. When the experience started again, we started to use calcium blockers extensively. Today I believe that this is not so important. Of course, during operations, we touch the conduit, but now it has been demonstrated that nitroglycerin is more effective than calcium blockers to relieve spasm. Today we are using nitroglycerin intravenously, and in the first weeks we are still giving calcium blockers, but I think that this aspect is not the most important issue for the patency rate of the RA. I think that the technical aspect and the choice of the correct territory is the key point for the satisfying patency rate. The pharmacologic aspect becomes less important.
Dr Brian Buxton (Heidelberg, Australia). You are a few years ahead of us with the number of RA grafts and ITA grafts that you have been performing. I have the impression that the RA does not quite match up to the free RITA, although your results here suggest that they do. If you had a crystal ball, what would you think would happen over an extended period of time?
Do you think it is just as valid to use an RA as the Y graft component, or do you think that there is still a very important role for Dr Tector's operation, in which the RITA is attached to the side of the LITA? In other words, do you think there is any difference? I know you show there is none.
Dr Calafiore. I think that today the best operation always is to use the 2 thoracic arteries, perhaps in the Y or T graft, as Dr Tector proposed. But what I think is important is the message that the RA is a second arterial conduit that can be used with very good results. I think that many surgeons will use a second conduit if this is an RA because it has a good size and can be harvested contemporaneously with the LITA. Many surgeons will not use the RITA every day in every patient. Today my policy is still to use 2 thoracic arteries for the great majority of patients. However, I think that the knowledge that the patency rate of the RA in selected cases is pretty good is important information and a positive message to send.
Dr O. Wayne Isom (New York, NY). There was one thing you did not mention. Did you notice, in the patients with bilateral ITA harvesting, any increase in sternal infection?
Dr Calafiore. In 1994 and 1995 we completely changed the method of dissecting ITAs that were skeletonized during harvesting. It was demonstrated, both in necropsies and studying the sternal vascularization after bilateral ITA harvesting, that the skeletonization preserves the sternum from the devascularization that follows the harvesting of both ITAs. We used a lot of RAs in the first part of our experience because the RITA was not used in diabetic patients. Now we are using the RITA in all the patients who have so-called risk factors such as obesity and diabetes.
Dr Isom. You do not notice any difference in infection?
Dr Calafiore. No. There is no difference in the infection rate or in the major sternal problems in patients with 1 or 2 ITAs if skeletonized.
| Footnotes |
|---|
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
B. Medalion, A. Tobar, Z. Yosibash, A. Stamler, E. Sharoni, E. Snir, E. Porat, and E. Hochhauser Vasoreactivity and histology of the radial artery: comparison of open versus endoscopic approaches Eur. J. Cardiothorac. Surg., October 1, 2008; 34(4): 845 - 849. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Glineur, C. Hanet, A. Poncelet, W. D'hoore, J.-C. Funken, J. Rubay, J. Kefer, P. Astarci, V. Lacroix, R. Verhelst, et al. Comparison of Bilateral Internal Thoracic Artery Revascularization Using In Situ or Y Graft Configurations: A Prospective Randomized Clinical, Functional, and Angiographic Midterm Evaluation Circulation, September 30, 2008; 118(14_suppl_1): S216 - S221. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bleiziffer, I. Hettich, B. Eisenhauer, D. Ruzicka, M. Wottke, J. Hausleiter, S. Martinoff, M. Morgenstern, and R. Lange Patency rates of endoscopically harvested radial arteries one year after coronary artery bypass grafting J. Thorac. Cardiovasc. Surg., September 1, 2007; 134(3): 649 - 656. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Pevni, I. Hertz, B. Medalion, A. Kramer, Y. Paz, G. Uretzky, and R. Mohr Angiographic evidence for reduced graft patency due to competitive flow in composite arterial T-grafts J. Thorac. Cardiovasc. Surg., May 1, 2007; 133(5): 1220 - 1225. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kulik, F. D. Rubens, D. Gunning, M. E. Bourke, T. G. Mesana, and M. Ruel Radial Artery Graft Treatment With Phenoxybenzamine is Clinically Safe and May Reduce Perioperative Myocardial Injury Ann. Thorac. Surg., February 1, 2007; 83(2): 502 - 509. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. B. Barner Status of percutaneous coronary intervention and coronary artery bypass. Eur. J. Cardiothorac. Surg., September 1, 2006; 30(3): 419 - 424. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. G. Nezic, A. M. Knezevic, P. S. Milojevic, B. P. Dukanovic, M. D. Jovic, M. D. Borzanovic, and A. N. Neskovic The fate of the radial artery conduit in coronary artery bypass grafting surgery. Eur. J. Cardiothorac. Surg., August 1, 2006; 30(2): 341 - 346. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhang, T. Tazzeo, V. Chu, and L. J. Janssen Membrane potassium currents in human radial artery and their regulation by nitric oxide donor Cardiovasc Res, July 15, 2006; 71(2): 383 - 392. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Orlov, J. Gurevitch, A. Kogan, V. Rubchevsky, A. Y. Zlotnick, and D. Aravot Multiple Arterial Revascularization Using the Tangential K-Graft Technique Ann. Thorac. Surg., November 1, 2005; 80(5): 1948 - 1950. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. F. Buxton, M. Durairaj, D. L. Hare, I. Gordon, S. Moten, V. Orford, and S. Seevanayagam Do Angiographic Results From Symptom-Directed Studies Reflect True Graft Patency? Ann. Thorac. Surg., September 1, 2005; 80(3): 896 - 901. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Fukui, S. Takanashi, Y. Hosoda, and S. Suehiro Total Arterial Myocardial Revascularization Using Composite and Sequential Grafting With the Off-Pump Technique Ann. Thorac. Surg., August 1, 2005; 80(2): 579 - 585. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. R. Sajja, G. Mannam, N. R. Pantula, and S. Sompalli Role of Radial Artery Graft in Coronary Artery Bypass Grafting Ann. Thorac. Surg., June 1, 2005; 79(6): 2180 - 2188. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Acar, R. C. Cook, S. G. Raja, S. Hashim, I. Birdi, P. J. Shah, R. A. Baker, J. J. Knight, U. N. Khot, D. T. Friedman, et al. Letters Regarding Article by Khot et al, "Radial Artery Bypass Grafts Have an Increased Occurrence of Angiographically Severe Stenosis and Occlusion Compared With Left Internal Mammary Arteries and Saphenous Vein Grafts" * Letters Regarding Article by Khot et al, "Radial Artery Bypass Grafts Have an Increased Occurrence of Angiographically Severe Stenosis and Occlusion Compared With Left Internal Mammary Arteries and Saphenous Vein Grafts" * Letters Regarding Article by Khot et al, "Radial Artery Bypass Grafts Have an Increased Occurrence of Angiographically Severe Stenosis and Occlusion Compared With Left Internal Mammary Arteries and Saphenous Vein Grafts" * Letters Regarding Article by Khot et al, "Radial Artery Bypass Grafts Have an Increased Occurrence of Angiographically Severe Stenosis and Occlusion Compared With Left Internal Mammary Arteries and Saphenous Vein Grafts" * Response Circulation, January 4, 2005; 111(1): e6 - e9. [Full Text] [PDF] |
||||
![]() |
S. Verma, P. E. Szmitko, R. D. Weisel, D. Bonneau, D. Latter, L. Errett, Y. LeClerc, and S. E. Fremes Should Radial Arteries Be Used Routinely for Coronary Artery Bypass Grafting? Circulation, August 3, 2004; 110(5): e40 - e46. [Full Text] [PDF] |
||||
![]() |
A. G. Royse, C. F. Royse, A. Maleskar, and A. Garg Harvest of the radial artery for coronary artery surgery preserves maximal blood flow of the forearm Ann. Thorac. Surg., August 1, 2004; 78(2): 539 - 542. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Manabe, N. Tabuchi, M. Toyama, T. Yoshizaki, M. Kato, H. Wu, M. Kotani, and M. Sunamori Oxygen pressure measurement during grip exercise reveals exercise intolerance after radial harvest Ann. Thorac. Surg., June 1, 2004; 77(6): 2066 - 2070. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Zacharias, R. H. Habib, T. A. Schwann, C. J. Riordan, S. J. Durham, and A. Shah Improved Survival With Radial Artery Versus Vein Conduits in Coronary Bypass Surgery With Left Internal Thoracic Artery to Left Anterior Descending Artery Grafting Circulation, March 30, 2004; 109(12): 1489 - 1496. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. S. Maniar, H. B. Barner, M. S. Bailey, S. M. Prasad, M. R. Moon, M. K. Pasque, M. L. Lester, W. A. Gay, and R. J. Damiano Radial artery patency: are aortocoronary conduits superior to composite grafting? Ann. Thorac. Surg., November 1, 2003; 76(5): 1498 - 1504. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Conant, M. J. Shackcloth, A. Y. Oo, M. R. Chester, A. W. M. Simpson, and W. C. Dihmis Phenoxybenzamine treatment is insufficient to prevent spasm in the radial artery: the effect of other vasodilators J. Thorac. Cardiovasc. Surg., August 1, 2003; 126(2): 448 - 454. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. J. Woo and T. J. Gardner Myocardial Revascularization with Cardiopulmonary Bypass Card. Surg. Adult, January 1, 2003; 2(2003): 581 - 607. [Full Text] |
||||
![]() |
R. Cartier, M. Leacche, and P. Couture Changing pattern in beating heart operations: use of skeletonized internal thoracic artery Ann. Thorac. Surg., November 1, 2002; 74(5): 1548 - 1552. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||